REGENXBIO, Inc. (RGNX)
8.06
-2.66
(-24.81%)
USD |
NASDAQ |
Aug 24, 16:00
8.08
+0.02
(+0.25%)
After-Hours: 20:00
REGENXBIO Total Assets (Quarterly) : 386.62M for June 30, 2026
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 386.62M |
| March 31, 2026 | 341.89M |
| December 31, 2025 | 453.03M |
| September 30, 2025 | 525.20M |
| June 30, 2025 | 581.03M |
| March 31, 2025 | 490.93M |
| December 31, 2024 | 465.99M |
| September 30, 2024 | 519.11M |
| June 30, 2024 | 569.38M |
| March 31, 2024 | 629.22M |
| December 31, 2023 | 573.97M |
| September 30, 2023 | 633.79M |
| June 30, 2023 | 682.46M |
| March 31, 2023 | 747.83M |
| December 31, 2022 | 833.27M |
| September 30, 2022 | 883.79M |
| June 30, 2022 | 953.44M |
| March 31, 2022 | 1.025B |
| December 31, 2021 | 1.114B |
| September 30, 2021 | 800.40M |
| June 30, 2021 | 836.40M |
| March 31, 2021 | 879.44M |
| December 31, 2020 | 708.16M |
| Date | Value |
|---|---|
| September 30, 2020 | 541.17M |
| June 30, 2020 | 449.74M |
| March 31, 2020 | 463.94M |
| December 31, 2019 | 497.91M |
| September 30, 2019 | 509.24M |
| June 30, 2019 | 529.14M |
| March 31, 2019 | 519.03M |
| December 31, 2018 | 543.81M |
| September 30, 2018 | 514.98M |
| June 30, 2018 | 335.99M |
| March 31, 2018 | 317.22M |
| December 31, 2017 | 198.68M |
| September 30, 2017 | 209.26M |
| June 30, 2017 | 224.38M |
| March 31, 2017 | 224.13M |
| December 31, 2016 | 172.73M |
| September 30, 2016 | 195.98M |
| June 30, 2016 | 206.07M |
| March 31, 2016 | 214.98M |
| December 31, 2015 | 221.38M |
| September 30, 2015 | 227.31M |
| June 30, 2015 | 88.80M |
| March 31, 2015 | 27.33M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| AbbVie, Inc. | 135.12B |
| Capricor Therapeutics, Inc. | 368.74M |
| Biogen, Inc. | 32.09B |
| Ardelyx, Inc. | 575.89M |
| Ocugen, Inc. | 124.21M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 314.85M |
| Shareholders Equity (Quarterly) | 71.76M |
| Debt to Equity Ratio | 3.49 |
| Current Ratio | 2.858 |
| Net Debt Paydown Yield | -3.60% |